Name | Role | Date | Shares | Price | Value |
---|---|---|---|---|---|
Craig Fraser | President and CEO | 2024-10-08 | 5,431 | $0.91 | $4.94kBuy |
Name | Hold | Shares | Value | Type |
---|---|---|---|---|
Lph Investments Ltd | 1,262.73% | 46,232,085 | $36.52M | Insider |
Lees Pharmaceutical Holdings Ltd | 474.44% | 17,370,770 | $13.72M | Insider |
China Cardiovascular Focus Ltd | 220.25% | 8,063,861 | $6.37M | Insider |
James Huang | 168.04% | 6,152,576 | $4.86M | Insider |
Panacea Venture Healthcare Fund I LP | 123.65% | 4,527,345 | $3.58M | Insider |
Ivy Blue Holdings Ltd | 118.45% | 4,336,790 | $3.43M | Insider |
Lph II Investments Ltd | 109.48% | 4,008,234 | $3.17M | Insider |
Center Laboratories Inc | 67.69% | 2,478,176 | $1.96M | Insider |
Robert J. Capetola | 11.92% | 436,417 | $344.77k | Insider |
Christopher J. Schaber | 6.36% | 232,771 | $183.89k | Insider |